Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.

Weiss, Jared

Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck. [electronic resource] - Oral oncology 09 2018 - 46-51 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1879-0593

10.1016/j.oraloncology.2018.06.028 doi


Adult
Aged
Albumins--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carboplatin--administration & dosage
Cetuximab--administration & dosage
Chemoradiotherapy--adverse effects
Cisplatin--administration & dosage
Combined Modality Therapy
Drug Eruptions--etiology
Female
Head and Neck Neoplasms--drug therapy
Humans
Induction Chemotherapy
Kaplan-Meier Estimate
Male
Middle Aged
Neoadjuvant Therapy--adverse effects
Neoplasm Staging
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Progression-Free Survival
Radiotherapy, Intensity-Modulated--adverse effects
Squamous Cell Carcinoma of Head and Neck--drug therapy
Treatment Outcome